Tag: CNIO
-
Immune-Related Genes Shape Pancreatic Cancer Risk and Outcomes, CNIO Study Finds
Overview: Immune Genes and pancreatic cancer In a significant advance for pancreatic cancer research, scientists from the National Cancer Research Centre (CNIO) have identified immune-related genetic variations that affect both the risk of developing pancreatic ductal adenocarcinoma (PDAC) and the outcomes for patients who face this challenging disease. The study adds to the growing body…
-
Immune-Related Genes Shape Pancreatic Cancer Risk and Outcomes Identified
Groundbreaking Discovery in Pancreatic Cancer Genetics Researchers at the National Cancer Research Centre (CNIO) have identified immune-related genetic variants that influence both the risk of developing pancreatic ductal adenocarcinoma (PDAC) and the disease’s survival outcomes after diagnosis. This large-scale genetic analysis highlights how the immune system’s genetic blueprint can shape cancer susceptibility and progression, offering…
-
Immune-Related Genes Shape Pancreatic Cancer Risk and Outcomes
Groundbreaking Findings Link Immune-Related Genes to Pancreatic Cancer Risk A new wave of genetic research from the National Cancer Research Centre (CNIO) is reshaping our understanding of pancreatic ductal adenocarcinoma (PDAC). Scientists have identified specific immune-related gene variations that not only influence a person’s risk of developing PDAC but also shape outcomes after diagnosis. The…